{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:10:59Z","timestamp":1764745859796,"version":"3.46.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.7759\/cureus.98349","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:05:54Z","timestamp":1764745554000},"source":"Crossref","is-referenced-by-count":0,"title":["Evolving Nature of Tuberculosis in the Post-pandemic World"],"prefix":"10.7759","author":[{"given":"Tamanna","family":"Bordoloi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Bala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Nityadarshini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raunak","family":"Bir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anant","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urvashi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46353","article-title":"Sequence of COVID-19 vaccination and COVID-19 infection and their association with the development of active tuberculosis: a case-control study","volume":"15","author":"Palupi S","year":"2023","unstructured":"Palupi S, Pambudi I, Surya A, et al.. Sequence of COVID-19 vaccination and COVID-19 infection and their association with the development of active tuberculosis: a case-control study. Cureus. 2023, 15:e46353. 10.7759\/cureus.46353","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2019.02.002","article-title":"Journey of tuberculosis control in India","volume":"66","author":"Arora VK","year":"2019","unstructured":"Arora VK, Chopra KK. Journey of tuberculosis control in India. Indian J Tuberc. 2019, 66:178-83. 10.1016\/j.ijtb.2019.02.002","journal-title":"Indian J Tuberc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13637","article-title":"COVID-19 and tuberculosis coinfection: an overview of case reports\/case series and meta-analysis of prevalence studies","volume":"9","author":"Daneshvar P","year":"2023","unstructured":"Daneshvar P, Hajikhani B, Sameni F, et al.. COVID-19 and tuberculosis coinfection: an overview of case reports\/case series and meta-analysis of prevalence studies. Heliyon. 2023, 9:e13637. 10.1016\/j.heliyon.2023.e13637","journal-title":"Heliyon"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2020.07.003","article-title":"COVID-19-tuberculosis interactions: when dark forces collide","volume":"67","author":"Udwadia ZF","year":"2020","unstructured":"Udwadia ZF, Vora A, Tripathi AR, Malu KN, Lange C, Sara Raju R. COVID-19-tuberculosis interactions: when dark forces collide. Indian J Tuberc. 2020, 67:S155-62. 10.1016\/j.ijtb.2020.07.003","journal-title":"Indian J Tuberc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107892","article-title":"World TB Day 2025 Theme \"Yes! We Can End TB: Commit, Invest, Deliver\" can be made a reality through concerted global efforts to advance diagnosis, treatment and research of tuberculosis infection and disease","volume":"155","author":"Goletti D","year":"2025","unstructured":"Goletti D, Matteelli A, Cliff JM, Meintjes G, Graham S, Esmail H, Shan Lee S. World TB Day 2025 Theme \"Yes! We Can End TB: Commit, Invest, Deliver\" can be made a reality through concerted global efforts to advance diagnosis, treatment and research of tuberculosis infection and disease. Int J Infect Dis. 2025, 155:107892. 10.1016\/j.ijid.2025.107892","journal-title":"Int J Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_2763_20","article-title":"COVID-19 & the National Tuberculosis Elimination Programme of India","volume":"153","author":"Behera D","year":"2021","unstructured":"Behera D, Behera RK. COVID-19 & the National Tuberculosis Elimination Programme of India. Indian J Med Res. 2021, 153:533-6. 10.4103\/ijmr.IJMR_2763_20","journal-title":"Indian J Med Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.07.034","article-title":"Tuberculosis in the era of COVID-19 in India","volume":"14","author":"Jain VK","year":"2020","unstructured":"Jain VK, Iyengar KP, Samy DA, Vaishya R. Tuberculosis in the era of COVID-19 in India. Diabetes Metab Syndr. 2020, 14:1439-43. 10.1016\/j.dsx.2020.07.034","journal-title":"Diabetes Metab Syndr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/lungindia.lungindia_544_20","article-title":"Tuberculosis, COVID-19, and the End Tuberculosis strategy in India","volume":"37","author":"Behera D","year":"2020","unstructured":"Behera D. Tuberculosis, COVID-19, and the End Tuberculosis strategy in India. Lung India. 2020, 37:467-72. 10.4103\/lungindia.lungindia_544_20","journal-title":"Lung India"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5005\/ijcdas-62-4-203","article-title":"National TB Elimination Programme-can it end TB in India by 2025: an appraisal","volume":"62","author":"Behera D","year":"2020","unstructured":"Behera D, Pannu VP, Behera RK. National TB Elimination Programme-can it end TB in India by 2025: an appraisal. Indian J Chest Dis Allied Sci. 2020, 62:203-27. 10.5005\/ijcdas-62-4-203","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"ref10","unstructured":"Definitions and reporting framework for tuberculosis - 2013 revision. updated December 2014 and January 2020. (2013). Accessed: 2025: https:\/\/www.who.int\/publications\/i\/item\/9789241505345."},{"key":"ref11","unstructured":"Guidelines. (2025). Accessed. 2025: https:\/\/tbcindia.mohfw.gov.in\/guidelines\/."},{"key":"ref12","unstructured":"ZN microscopy. staining process. (2023). Accessed: 2025: https:\/\/ntep.in\/index.php\/node\/293\/CP-zn-microscopy-staining-process."},{"key":"ref13","unstructured":"MGIT 960 instrument. principle for culture. (2023). Accessed: 2025: https:\/\/ntep.in\/index.php\/node\/1462\/CP-mgit-960-instrument-principle-culture."},{"key":"ref14","unstructured":"Cartridge based nucleic acid amplification test [CBNAAT]. (2023). Accessed. 2025: https:\/\/ntep.in\/node\/397\/CP-cartridge-based-nucleic-acid-amplification-test-cbnaat."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02328-2020","article-title":"On tuberculosis and COVID-19 co-infection","volume":"56","author":"Tadolini M","year":"2020","unstructured":"Tadolini M, Garc\u00eda-Garc\u00eda JM, Blanc FX, et al.. On tuberculosis and COVID-19 co-infection. Eur Respir J. 2020, 56:2002328. 10.1183\/13993003.02328-2020","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2020.102020","article-title":"Pathology of TB\/COVID-19 co-infection: the phantom menace","volume":"126","author":"Mousquer GT","year":"2021","unstructured":"Mousquer GT, Peres A, Fiegenbaum M. Pathology of TB\/COVID-19 co-infection: the phantom menace. Tuberculosis (Edinb). 2021, 126:102020. 10.1016\/j.tube.2020.102020","journal-title":"Tuberculosis (Edinb)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132557","article-title":"Blood monocytes: development, heterogeneity, and relationship with dendritic cells","volume":"27","author":"Auffray C","year":"2009","unstructured":"Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009, 27:669-92. 10.1146\/annurev.immunol.021908.132557","journal-title":"Annu Rev Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2025.02.012","article-title":"Trained immunity-based mucosal immunotherapies for the prevention of respiratory infections","volume":"46","author":"Minute L","year":"2025","unstructured":"Minute L, Montalb\u00e1n-Hern\u00e1ndez K, Bravo-Robles L, Conejero L, Iborra S, Del Fresno C. Trained immunity-based mucosal immunotherapies for the prevention of respiratory infections. Trends Immunol. 2025, 46:270-83. 10.1016\/j.it.2025.02.012","journal-title":"Trends Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837524","article-title":"Trained immunity: an overview and the impact on COVID-19","volume":"13","author":"Brueggeman JM","year":"2022","unstructured":"Brueggeman JM, Zhao J, Schank M, Yao ZQ, Moorman JP. Trained immunity: an overview and the impact on COVID-19. Front Immunol. 2022, 13:837524. 10.3389\/fimmu.2022.837524","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar LE","year":"2020","unstructured":"Escobar LE, Molina-Cruz A, Barillas-Mury C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc Natl Acad Sci U S A. 2020, 117:17720-6. 10.1073\/pnas.2008410117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piae013","article-title":"Impact of BCG vaccination disruptions during the COVID-19 pandemic on tuberculosis incidence in infants: a nationwide study in Brazil","volume":"13","author":"Procianoy GS","year":"2024","unstructured":"Procianoy GS, Cotrim MW, Cia LO, Behar PR. Impact of BCG vaccination disruptions during the COVID-19 pandemic on tuberculosis incidence in infants: a nationwide study in Brazil. J Pediatric Infect Dis Soc. 2024, 13:186-8. 10.1093\/jpids\/piae013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1273938","article-title":"Vaccine development against tuberculosis before and after COVID-19","volume":"14","author":"Kaufmann SH","year":"2023","unstructured":"Kaufmann SH. Vaccine development against tuberculosis before and after COVID-19. Front Immunol. 2023, 14:1273938. 10.3389\/fimmu.2023.1273938","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen J","year":"2023","unstructured":"Chen J, Gao L, Wu X, et al.. BCG-induced trained immunity: history, mechanisms and potential applications. J Transl Med. 2023, 21:106. 10.1186\/s12967-023-03944-8","journal-title":"J Transl Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2022.101031","article-title":"Tuberculosis and COVID-19: a combined global threat to human civilization","volume":"15","author":"Patra K","year":"2022","unstructured":"Patra K, Batabyal S, Mandal K, Ghose D, Sarkar J. Tuberculosis and COVID-19: a combined global threat to human civilization. Clin Epidemiol Glob Health. 2022, 15:101031. 10.1016\/j.cegh.2022.101031","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI166467","article-title":"Beyond adaptive immunity: induction of trained immunity by COVID-19 adenoviral vaccines","volume":"133","author":"Netea MG","year":"2023","unstructured":"Netea MG, Joosten LA. Beyond adaptive immunity: induction of trained immunity by COVID-19 adenoviral vaccines. J Clin Invest. 2023, 133:e166467. 10.1172\/JCI166467","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.059","article-title":"Non-specific effect of Bacille Calmette-Gu\u00e9rin vaccine on the immune response to routine immunisations","volume":"31","author":"Ritz N","year":"2013","unstructured":"Ritz N, Mui M, Balloch A, Curtis N. Non-specific effect of Bacille Calmette-Gu\u00e9rin vaccine on the immune response to routine immunisations. Vaccine. 2013, 31:3098-103. 10.1016\/j.vaccine.2013.03.059","journal-title":"Vaccine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/427335-evolving-nature-of-tuberculosis-in-the-post-pandemic-world","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:05:55Z","timestamp":1764745555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/427335-evolving-nature-of-tuberculosis-in-the-post-pandemic-world"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.98349","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}